The treatment of malignant diseases during childhood leads to variable growth problems which have been studied in some detail. ' The effects on growth of the actual disease processes themselves have been relatively neglected, but in a preliminary study2 the observation was made that a group of Sheffield children with untreated leukaemia were significantly taller than their healthy peers. To confirm or Trial, UKALL I. age of4. 3 years, from 26 centres scattered throughout the United Kingdom, were studied. Of these 140 were boys and 96 girls. The group as a whole was significantly taller than the normal population (P<0.0001). There was no difference between the sexes, nor was there a difference between those older and younger than the median age. Of the four subgroups (boys <4-3 years, boys >4 3 years, girls <4-3 years, girls >4-3 years), all except the boys >4-3 years were significantly taller than normal (Table and Figure. 
